MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-GJ-01-0193153
Xenosys Biotech Private Limited - pharma in Sanand, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.15 Cr
▼ 42% YoY
Net profit · FY 2025
₹93,146
Net margin 0.8%
EBITDA · FY 2025
₹2.57 Lakh
EBITDA margin 2.2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Xenosys Biotech Private Limited
Data last updated:
Xenosys Biotech Private Limited is a private limited company based in Sanand, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 September 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24110GJ2020PTC116385. Its GSTIN is 24AAACX3395G1Z9 (Gujarat).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Jagat Srivastava and Prakash Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 60 Shri Sharan Business Park, Sanand, Gujarat.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.15 Cr, a decline of 42% compared to the previous year. For the same year it recorded a net profit of ₹93,146 (net margin 0.8%) and EBITDA of ₹2.57 Lakh (EBITDA margin 2.2%). Revenue has declined at a compounded annual rate (CAGR) of 22% over three years.
Court records list 2 cases involving the company, including 2 filed by the company.
Xenosys Biotech Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0193153). For more details, the company can be reached via its website xenosysbiotech.com.
Company details
CIN U24110GJ2020PTC116385
Registration Number 116385
Incorporation Date 10 September 2020
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-GJ-01-0193153
Key People
Jagat Srivastava Director Prakash Kumar Director Recognitions & Rankings of Xenosys Biotech
Contact details
Xenosys Biotech Private Limited's registered office is in Sanand, Gujarat. Its website is xenosysbiotech.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressC/O Shivam Reality Shop No. 59 & 60 Shri Sharan Business Park Vill – Changoda, R, Sanand, Gujarat, India – 382213
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Xenosys Biotech Private Limited, buy the company report.
Comprehensive company report
Xenosys Biotech Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Xenosys Biotech is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Xenosys Biotech Private Limited, buy the company report.
Financials of Xenosys Biotech Private Limited
FY 2025 filings availableXenosys Biotech Private Limited reported revenue of ₹1.15 Cr (down 42% YoY) for FY 2025.
Revenue · FY 2025
₹1.15 Cr ▼ 42%
Net profit · FY 2025
₹93,146 margin 0.8%
EBITDA · FY 2025
₹2.57 Lakh margin 2.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 42%
3 years · compounded
▼ 22%
EBITDA CAGR growth
1 year
▼ 37%
3 years · compounded
▼ 8%
Revenue has declined at a compounded annual rate (CAGR) of 22% over three years, including a 42% fall in the latest year. EBITDA fell 37% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.57 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹93,146 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.2% | ||||
| Net Profit Margin | 0.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Xenosys Biotech Private Limited, buy the company report.
Board of directors of Xenosys Biotech Private Limited
Xenosys Biotech has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jagat Srivastava | Director | 10 Sep 2020 | 6 Years 1 Months | Current |
| Prakash Kumar | Director | 10 Sep 2020 | 6 Years 1 Months | Current |
Peer comparison
Xenosys Biotech Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Credas Labs Private Limited | ₹1.16 Cr (FY 2024) | -58.0% | Hyderabad, Telangana, India | |||
| Meghnagar Pharmachem Private Limited | ₹1.16 Cr (FY 2023) | -92.0% | Vadodara, Gujarat, India | |||
| Xenosys Biotech Private Limitedthis company | ₹1.15 Cr (FY 2025) | ₹93,146 | 0.8% | -42.0% | Sanand, Gujarat, India | |
| Bonjour Health Care Private Limited | ₹1.15 Cr (FY 2025) | 11.0% | New Delhi, Delhi, India | |||
| Taizi Pharma Private Limited | ₹1.15 Cr (FY 2023) | 184.0% | Bangalore, Karnataka, India |
To see the full peer comparison of Xenosys Biotech Private Limited, buy the company report.
Legal cases
Xenosys Biotech Private Limited has 2 court cases on record: 2 filed by Xenosys Biotech. All cases are disposed.
Total cases
2
Filed by the company
2
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 0 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ahmedabad, Gujarat | Court case (CR EN) | Filed by the company against D. A Pharmaceuticals(Piyush Patel) and 1 other | Disposed |
| District court, Ahmedabad, Gujarat | Court case (CR EN) | Filed by the company against an individual | Disposed |
To see the full case history of Xenosys Biotech Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Xenosys Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Xenosys Biotech Private Limited has 1 active EPFO establishment as of Apr 05, 2024.
Active EPFO establishments
1
GST
Xenosys Biotech has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAACX3395G1Z9 | Gujarat | Active | 12 Oct 2020 |
To see the full GST registrations and return filing status of Xenosys Biotech Private Limited, buy the company report.
Recent activity
Xenosys Biotech Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Jagat Srivastava was appointed as Director on 10 Sep 2020.
AGM
Xenosys Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Xenosys Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Appointed
Jagat Srivastava was appointed as Director.
Appointed
Prakash Kumar was appointed as Director.
Incorporation
10 Sep 2020
Xenosys Biotech Private Limited was registered on 10 Sep 2020 with Roc Ahmedabad & aged 6 years 1 month as per MCA records.
Frequently asked questions
Xenosys Biotech is an active private limited company based in Sanand, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 September 2020 (6+ years old) and is registered under CIN U24110GJ2020PTC116385.
Xenosys Biotech has 2 current directors:
- Jagat Srivastava - Director
- Prakash Kumar - Director
The latest financial statements of Xenosys Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Xenosys Biotech is 24AAACX3395G1Z9, registered in Gujarat.
The CIN (Corporate Identification Number) of Xenosys Biotech is U24110GJ2020PTC116385. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Xenosys Biotech has 2 court cases on record: 2 filed by the company.
Xenosys Biotech was incorporated on 10 September 2020, making it 6+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Xenosys Biotech by revenue are Credas Labs Private Limited, Meghnagar Pharmachem Private Limited, Bonjour Health Care Private Limited, Taizi Pharma Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Jagat Srivastava was appointed as Director on 10 Sep 2020. Prakash Kumar was appointed as Director on 10 Sep 2020.
Yes, Xenosys Biotech is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-01-0193153).
Xenosys Biotech can be reached through the website xenosysbiotech.com. Its registered office is in Sanand, Gujarat, India.